About NIMGenetics
NIMGenetics is a company based in Madrid (Spain) founded in 2007 was acquired by Veritas Genetics in January 2025.. NIMGenetics has raised $7.63 million across 2 funding rounds from investors including Veritas Genetics, European Union and Apposite Capital. NIMGenetics has completed 1 acquisition, including Gene Predictis. NIMGenetics offers products and services including TrisoNIM, GenoNIM, ExoNIM, and NIMSeq. NIMGenetics operates in a competitive market with competitors including MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.63 M (USD)
in 2 rounds
-
Latest Funding Round
$7.63 M (USD), Series A
May 10, 2017
-
Investors
Veritas Genetics
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Veritas Genetics
(Jan 20, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NIMGenetics
NIMGenetics offers a comprehensive portfolio of products and services, including TrisoNIM, GenoNIM, ExoNIM, and NIMSeq. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects aneuploidies and deletions for prenatal diagnostics.
Enables genomic analysis for various medical applications.
Provides complete exome analysis for genetic disorders.
Offers sequencing services for prenatal and postnatal testing.
Unlock access to complete
Funding Insights of NIMGenetics
NIMGenetics has successfully raised a total of $7.63M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7.63 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $7.6M
-
First Round
First Round
(01 Jan 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Series A - NIMGenetics | Valuation | Apposite Capital |
|
| Jan, 2017 | Amount | Grant - NIMGenetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NIMGenetics
NIMGenetics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Veritas Genetics, European Union and Apposite Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare impact investments are managed by Apposite Capital.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Genetic testing products for health risks and traits are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NIMGenetics
NIMGenetics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Gene Predictis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomic tests are developed for personalized medicine risks.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NIMGenetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nimgenetics Comparisons
Competitors of NIMGenetics
NIMGenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nimgenetics
Frequently Asked Questions about NIMGenetics
When was NIMGenetics founded?
NIMGenetics was founded in 2007 and raised its 1st funding round 10 years after it was founded.
Where is NIMGenetics located?
NIMGenetics is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Is NIMGenetics a funded company?
NIMGenetics is a funded company, having raised a total of $7.63M across 2 funding rounds to date. The company's 1st funding round was a Grant of $260.91K, raised on Jan 01, 2017.
What does NIMGenetics do?
Diagnostic solutions based on microarray and next-generation sequencing technologies. The company develops products for both the clinical and research markets. It has three product families for clinical diagnostics TRISONIM, a non-invasive prenatal test for the most commonly diagnosed fetal abnormalities KARYONIM, a range of products for invasive fetal and neonatal testing for chromosomal abnormalities and ONCONIM, which contains one test for BRCA testing, and two gene panels for enabling precision medicine in cancer patients. In addition, NIMGenetics has NIMFISH which is a range of customized FISH probes and EXONIM for whole exome sequencing. NIMGenetics is certified by Life Technologies (now ThermoFisher) for exome sequencing.
Who are the top competitors of NIMGenetics?
NIMGenetics's top competitors include Foundation Medicine, MedGenome and Personalis.
What products or services does NIMGenetics offer?
NIMGenetics offers TrisoNIM, GenoNIM, ExoNIM, and NIMSeq.
How many acquisitions has NIMGenetics made?
NIMGenetics has made 1 acquisition, including Gene Predictis.
Who are NIMGenetics's investors?
NIMGenetics has 3 investors. Key investors include Veritas Genetics, European Union, and Apposite Capital.